LivaNova (LIVN) FCF Margin (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,364.00 |
| Dec 31, 2025 | -348.00 |
| Sep 30, 2025 | 383.00 |
| Jun 30, 2025 | 939.00 |
| Mar 31, 2025 | -1,706.00 |
| Dec 31, 2024 | 1,090.00 |
| Sep 30, 2024 | 53.00 |
| Jun 30, 2024 | 858.00 |
| Mar 31, 2024 | -1,202.00 |
| Dec 31, 2023 | 994.00 |
| Sep 30, 2023 | 1,132.00 |
| Jun 30, 2023 | -1,299.00 |
| Mar 31, 2023 | 148.00 |
| Dec 31, 2022 | -824.00 |
| Sep 30, 2022 | 1,816.00 |
| Jun 30, 2022 | -1,502.00 |
| Mar 31, 2022 | -101.00 |
| Dec 31, 2021 | 142.00 |
| Sep 30, 2021 | 90.00 |
| Jun 30, 2021 | 272.00 |
| Mar 31, 2021 | -673.00 |
| Dec 31, 2020 | 1,204.00 |
| Sep 30, 2020 | 1,481.00 |
| Jun 30, 2020 | 3,172.00 |
| Mar 31, 2020 | -4,555.00 |
| Dec 31, 2019 | 2,900.00 |
| Sep 30, 2019 | -2,193.00 |
| Jun 30, 2019 | -732.00 |
| Mar 31, 2019 | -420.00 |
| Dec 31, 2018 | -1,172.00 |
| Sep 30, 2018 | 694.00 |
| Jun 30, 2018 | 167.00 |
| Mar 31, 2018 | 267.00 |
| Dec 31, 2017 | -1,000.00 |
| Sep 30, 2017 | 1,666.00 |
| Jun 30, 2017 | -1,482.00 |
| Mar 31, 2017 | -126.00 |
| Dec 31, 2016 | 230.00 |
| Oct 18, 2015 | 5,133.00 |
| Jul 24, 2015 | 1,932.00 |